3HAT image
Deposition Date 1994-10-16
Release Date 1995-02-27
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3HAT
Title:
ACTIVE SITE MIMETIC INHIBITION OF THROMBIN
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Observed:
0.14
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Thrombin heavy chain
Gene (Uniprot):F2
Chain IDs:B (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Hirudin variant-2
Chain IDs:C (auth: I)
Chain Length:12
Number of Molecules:1
Biological Source:Hirudo medicinalis
Polymer Type:polypeptide(L)
Molecule:Thrombin light chain
Gene (Uniprot):F2
Chain IDs:A (auth: L)
Chain Length:36
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:FPAM (FIBRINOPEPTIDE A MIMIC)
Chain IDs:D (auth: T)
Chain Length:4
Number of Molecules:1
Biological Source:synthetic construct
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TYS C TYR modified residue
Primary Citation
Active-site mimetic inhibition of thrombin.
Acta Crystallogr.,Sect.D 51 550 559 (1995)
PMID: 15299843 DOI: 10.1107/S0907444994013132

Abstact

The structures of two mimetic inhibitor complexes of human alpha-thrombin have been determined by X-ray crystallography. One mimics a beta-turn with a bicyclic ring system; the other mimics two different active-site binding modes. The beta-turn mimetic is used to approximate a turn found in the conformation of fibrinopeptide A, which is catalytically released by thrombin in the activation of fibrinogen to fibrin. The binding of the second mimetic is a hybrid between normal substrate and the abnormal binding of the potent natural leech inhibitor hirudin. The binding of the beta-turn mimetic is tenuous, because it is like a substrate, while that of the substrate-hirudin hybrid is that of a tenacious inhibitor (which it is). Structurally retrospect modifications for rational design and improvement of both mimetic inhibitors are proposed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures